HEALTH CANADA AUTHORIZES PROMETIC TO PROCEED WITH ITS PBI-4050 CLINICAL TRIAL IN PATIENTS WITH CYSTIC FIBROSIS

May 18, 2016
Posted by: Prometic Prometic
Posted In: Press Releases 2016
X